phase readout

NCT07375316: A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy

RECRUITINGupdated 2h ago

community read0 votes

Sponsor: Guangdong Association of Clinical Trials. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

Data sources

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?